Drug Trial Radar · NCT06591793
Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Jul 2, 2024
Primary completion
Jan 2031
Study completion Jul 2031
Sponsor
- Lead sponsor
- AAVantgarde Bio SrlIndustry
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the 081-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-081 in USH1B patients with retinitis pigmentosa due to a mutation in the MYO7A gene. The study will also assess the initial efficacy following AAVB-081 administration.
Conditions
- Usher Syndrome, Type 1B
Interventions
AAVB-081Biological
Single subretinal administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- To measure the number and severity of treatment related adverse events following treatment with AAVB-081Time frame: 63 months
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
University of Campania Luigi Vanvitelli
Naples, Italy
Moorfields Eye Hospital
London, United Kingdom
Retina Clinic London
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.